![]() |
University of Iowa Diagnostic Laboratories (UIDL) Department of Pathology Room 5231, RCP Iowa City, Iowa 52242-1181 319-384-7212 Tel 319-384-7213 Fax |
Dystrophy
|
Method |
Specimen
|
X-linked Recessive | ||
DMD, BMD, and manifesting carriers |
Immunofluorescence - screen with four dystrophin antibodies (carboxy terminus, two rod domain, and amino terminus); 12 additional antibodies available for more detailed epitope mapping [also use spectrin, α- and β-dystroglycan, sarcoglycans, utrophin, embryonic myosin heavy chain and nNOS antibodies to more completely evaluate muscle biopsies] |
Frozen muscle |
Emery-Dreifuss |
Immunofluorescence - emerin antibody (lamin A/C antibody used as positive control for integrity |
Frozen muscle or skin |
|
|
|
Autosomal Dominant |
||
FSHD1 and FSHD2 |
Southern blots - p13E-11 probe to identify 4q35 deletions - 4qA and 4qB haplotype testing - prenatal testing - methylation assay SMCHD1 sequencing |
Peripheral blood samples or prenatal CVS or amniocyte cultures |
LGMD 1B and EDMD | Sequencing LMNA gene | Peripheral blood |
LGMD 1C |
Immunofluorescence - caveolin-3 antibody |
Frozen muscle |
Myotonic Dystrophy (DM1) | Southern blot and PCR | Peripheral blood |
|
|
|
Autosomal Recessive | ||
LGMD 2A, 2B, 2C, 2D, 2E, 2F, 2I and other dystroglycanopathies |
|
Frozen muscle Peripheral blood |
CMD (various subtypes) |
Immunofluorescence - α-2-laminin (merosin) antibodies for merosin-deficient CMD (MDC1A) - α- and β-dystroglycan antibodies for dystroglycanopathies - collagen VI antibody in dual label protocol with anti-perlecan for Ullrich CMD Molecular genetic testing - FKRP sequencing for MDC1C - FKRP, FKTN, ISPD, POMT1, POMT2 sequencing for Walker-Warburg syndrome - POMGnT1 sequencing for muscle-eye- brain disease - FKTN sequencing or PCR for ancestral retrotransposon in Fukuyama CMD |
Frozen muscle or skin Frozen muscle Frozen muscle Peripheral blood |